Oral acyclovir in the treatment of genital herpes. Preliminary report of a multicenter trial.

Author: FiddianA P, HalsosA M, KingeB R, NilsenA E, WikstromK

Paper Details 
Original Abstract of the Article :
Ninety patients with genital herpes (29 initial and 61 recurrent episodes) were entered into a double-blind randomized trial of oral acyclovir and placebo. Treatment consisted of 200 mg acyclovir five times a day for five days or matching placebo. Therapy was initiated a mean of 2.8 days and 1.0 day...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0002-9343(82)90118-8

データ提供:米国国立医学図書館(NLM)

Oral Acyclovir: A Beacon of Hope for Genital Herpes

Genital herpes, a common and often persistent viral infection, can be as challenging to manage as a desert journey filled with unexpected obstacles. This study examines the effectiveness of oral acyclovir in treating both initial and recurrent episodes of genital herpes, evaluating its ability to reduce viral shedding, alleviate symptoms, and prevent new lesion formation. The authors aim to provide valuable insights into the use of oral acyclovir, potentially offering a more effective and convenient treatment option for individuals with genital herpes.

Navigating the Desert of Herpes: Oral Acyclovir's Impact

The study highlights the effectiveness of oral acyclovir in managing genital herpes, a condition that can be as persistent as a desert wind. The authors demonstrate that oral acyclovir significantly reduces viral shedding, shortens symptom duration, and effectively prevents the formation of new lesions. These findings are akin to a desert explorer discovering a new oasis, offering a potential respite from the challenges of this persistent condition. The study underscores the importance of exploring effective treatment options for genital herpes, potentially improving the quality of life for individuals affected by this condition.

A Path to Relief: Oral Acyclovir's Potential Benefits

Oral acyclovir provides a valuable treatment option for genital herpes, offering a potential path to relief from the discomfort and challenges associated with this condition. The study emphasizes the drug's ability to reduce viral shedding, alleviate symptoms, and prevent new lesions, potentially improving both physical and emotional well-being. The research serves as a guidepost in the ongoing quest for more effective and convenient treatments for genital herpes, potentially leading to a smoother and more comfortable journey through the desert of this persistent condition.

Dr. Camel's Conclusion

Genital herpes, a common viral infection, can be as persistent and challenging as a desert mirage. This study highlights the effectiveness of oral acyclovir in treating both initial and recurrent episodes of genital herpes, offering a potential path to relief. The research underscores the importance of exploring effective treatment options for genital herpes, potentially improving the quality of life for individuals affected by this condition. Like a skilled desert traveler seeking a safe haven, individuals with genital herpes can benefit from the insights gained from this study, potentially leading to a smoother and more comfortable journey through the desert of this persistent condition.
Date :
  1. Date Completed 1982-09-10
  2. Date Revised 2019-06-27
Further Info :

Pubmed ID

7048920

DOI: Digital Object Identifier

10.1016/0002-9343(82)90118-8

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.